Rifampin-induced acute kidney injury and hemolysis: A case report and literature review of a rare condition.

Autor: Ata F; Department of Endocrinology Hamad Medical Corporation Doha Qatar., Magboul HMB; Department of Internal Medicine Hamad Medical Corporation Doha Qatar., Toba HAA; Department of Internal Medicine Hamad Medical Corporation Doha Qatar., Alfar H; Department of Internal Medicine Hamad Medical Corporation Doha Qatar., Al Bozom A; Department of Internal Medicine Hamad Medical Corporation Doha Qatar., Murshed K; Department of Anatomic Pathology Hamad Medical Corporation Doha Qatar., Zahid M; Department of Internal Medicine Hamad Medical Corporation Doha Qatar.; Weill Cornell Medicine Doha Qatar.; College of Medicine Qatar University Doha Qatar.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2022 Dec 21; Vol. 10 (12), pp. e6780. Date of Electronic Publication: 2022 Dec 21 (Print Publication: 2022).
DOI: 10.1002/ccr3.6780
Abstrakt: Rifampicin is a bactericidal drug used in various infectious diseases, including tuberculosis (TB). Nephrotoxicity is a rare side effect of intermittent Rifampin use and even less commonly continued use. We report a case of Rifampin-induced acute tubular necrosis and hemolysis in a patient with latent TB with a relevant literature review.
Competing Interests: The authors declare that they have no competing interests.
(© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje